Companies: 10,795·Total market cap: $144.5T

Celyad Oncology S.A.

Celyad Oncology S.A.

CYADNASDAQHealthcare

$0.47

$-0.07(-12.96%)

Market Cap$14238462

P/E Ratio—

52W High$3.07

52W Low$0.15

Avg Volume19K

Open$0.52

Beta1.69

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Celyad Oncology S.A.（CYAD）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · CYAD · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.52Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)288000.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding41.4MShares outstanding history

Next EarningsTBAEarnings history

探索 Celyad Oncology S.A. 数据

分析师预测$— · Buy

股息不分红

营收$186000+82.35%

盈利EPS $-0.14+57.58%

财务快照

FY 2024Revenue$186000.00▲ +82.35% YoY

202220232024

FY 2024Net Income-$5.8M▲ +31.06% YoY

202220232024

FY 2024EPS$-0.14▲ +57.58% YoY

202220232024

TTM:Revenue: $288000.00Net Income: -$14.3MEPS: $-0.52View income statement →

分析师评级与目标价

Buy5 位分析师

Strong Buy

0

Buy

3

Hold

2

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$0.47Current

$—Avg Target

$—High

合计: 5 · 买入占比: 60.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Celyad Oncology S.A.

$0.47-12.96%$14.2M #2

AlphaTON Capital Corp.

$0.29+7.22%$659,570 #3

Axcella Health Inc.

$4.58+0.00%$12.5M #4

Gelesis Holdings, Inc.

$0.16+0.00%$11.6M #5

TuHURA Biosciences, Inc.

$2.05+4.07%$130.2M #6

$2.01-2.43%$5.1M

股票表现

1D+0.00%

1W+0.00%

1M-11.10%

3M-44.77%

YTD-6.00%

1Y-74.18%

5Y-98.23%

关于 Celyad Oncology S.A.

CEOGeorges Rawadi

IPO DateJun 19, 2015

Employees35

CountryBE

Websitecelyad.com

Celyad Oncology S.A. is a clinical-stage biopharmaceutical firm dedicated to pioneering and advancing novel chimeric antigen receptor T (CAR-T) cell therapies aimed at combating various cancers. The c…

Biotechnology HealthcareNASDAQADRBE

关于股票概览与关键数据

Celyad Oncology S.A.（CYAD）是 Biotechnology 行业的 Healthcare 类公司，于 Jun 19, 2015 在 NASDAQ 上市。截至最近交易日，CYAD 股价为 $0.47，市值约为 $14.2M。过去12个月累计回报 -74.18%，年初至今回报 -6.00%。

根据 5 位华尔街分析师，Celyad Oncology S.A. 股票共识评级为Buy，12个月平均目标价为 $—。2024 财年 Celyad Oncology S.A. 营收 $186000.00，净利润 -$5.8M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Celyad Oncology S.A.（CYAD）股价为 $0.47，在 NASDAQ 上市，52周区间为 $0.15 – $3.07。

CYAD 最新股价CYAD quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议